top of page
Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement.
Pluristyx provides the expertise and tools to support and accelerate the development and commercialization of revolutionary therapeutics to treat serious human diseases by providing unique products, consulting, and contract services.
bottom of page